Syndax Pharmaceuticals, Inc. (SNDX)
17.70
+0.74
(+4.36%)
USD |
NASDAQ |
Jun 09, 16:00
17.70
0.00 (0.00%)
After-Hours: 17:03
Syndax Pharmaceuticals Shareholders Equity (Quarterly) : 41.62M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Celldex Therapeutics, Inc. | 456.23M |
| Viridian Therapeutics, Inc. | 636.01M |
| Ardelyx, Inc. | 148.62M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 472.67M |
| Total Liabilities (Quarterly) | 431.05M |
| Debt to Equity Ratio | 8.298 |
| Current Ratio | 5.468 |
| Net Debt Paydown Yield | 0.00% |